Costs and New Technologies in Healthcare Delivery

Costs and New Technologies in Healthcare Delivery

Marie-Christine Thaize Challier
Copyright: © 2008 |Pages: 7
ISBN13: 9781599048895|ISBN10: 1599048892|EISBN13: 9781599048901
DOI: 10.4018/978-1-59904-889-5.ch039
Cite Chapter Cite Chapter

MLA

Thaize Challier, Marie-Christine. "Costs and New Technologies in Healthcare Delivery." Encyclopedia of Healthcare Information Systems, edited by Nilmini Wickramasinghe and Eliezer Geisler, IGI Global, 2008, pp. 290-296. https://doi.org/10.4018/978-1-59904-889-5.ch039

APA

Thaize Challier, M. (2008). Costs and New Technologies in Healthcare Delivery. In N. Wickramasinghe & E. Geisler (Eds.), Encyclopedia of Healthcare Information Systems (pp. 290-296). IGI Global. https://doi.org/10.4018/978-1-59904-889-5.ch039

Chicago

Thaize Challier, Marie-Christine. "Costs and New Technologies in Healthcare Delivery." In Encyclopedia of Healthcare Information Systems, edited by Nilmini Wickramasinghe and Eliezer Geisler, 290-296. Hershey, PA: IGI Global, 2008. https://doi.org/10.4018/978-1-59904-889-5.ch039

Export Reference

Mendeley
Favorite

Abstract

Reducing medical costs is one of the major policy questions. A well understanding of this issue requires specific insight into some domains. The three main points which must be clarified relate to: (1) the nature of the costs (production costs and transaction costs), (2) the nature of new healthcare technologies (the biotechnology and biomedical engineering vs. the e-healthcare system, the face-to-face communications between the primary care physicians or other providers and the patients vs. the non face-to-face communications), and (3) the nature of information (which can be asymmetric, incomplete, or imperfect). This article studies what differences there are when considerations about informational issues and types of medicine are taken into account in the modern health economy characterized by the generation and the implementation of new healthcare technologies. To do this, this article first clarifies and presents some concepts in the framework of the health economy. Then, from these issues, it discusses the cost containment in the current case of the development and adoption of new technologies, and contrasts the opinions and perspectives.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.